CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely
- 23 February 2002
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 10 (1) , 55-61
- https://doi.org/10.1016/s0966-3274(02)00014-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Requirement for CD40 Ligand in Costimulation Induction, T Cell Activation, and Experimental Allergic EncephalomyelitisScience, 1996
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathwaysNature, 1996
- Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signalsInternational Immunology, 1996
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- TRANSPLANTATION TOLERANCE INDUCED BY CTLA4-Ig1Transplantation, 1994
- How B and T cells talk to each otherNature, 1994
- Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1Science, 1992
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Adhesion receptors of the immune systemNature, 1990
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990